213 related articles for article (PubMed ID: 38066611)
1. Molecular subtypes of breast cancer predicting clinical benefits of radiotherapy after breast-conserving surgery: a propensity-score-matched cohort study.
Hung SK; Yang HJ; Lee MS; Liu DW; Chen LC; Chew CH; Lin CH; Lee CH; Li SC; Hong CL; Yu CC; Yu BH; Hsu FC; Chiou WY; Lin HY
Breast Cancer Res; 2023 Dec; 25(1):149. PubMed ID: 38066611
[TBL] [Abstract][Full Text] [Related]
2. 21-Gene recurrence score predictive for prognostic benefit of radiotherapy in patients age ≥ 70 with T1N0 ER/PR + HER2- breast cancer treated with breast conserving surgery and endocrine therapy.
Chevli N; Haque W; Tran KT; Farach AM; Schwartz MR; Hatch SS; Butler EB; Teh BS
Radiother Oncol; 2022 Sep; 174():37-43. PubMed ID: 35772577
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
[TBL] [Abstract][Full Text] [Related]
4. Role of 21-Gene Recurrence Score in Predicting Prognostic Benefit of Radiation Therapy After Breast-Conserving Surgery for T1N0 Breast Cancer.
Chevli N; Haque W; Tran KT; Farach AM; Schwartz MR; Hatch SS; Butler EB; Teh BS
Pract Radiat Oncol; 2023; 13(3):e230-e238. PubMed ID: 36038115
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
Wu SY; Tan Y; Guan YS
Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
[TBL] [Abstract][Full Text] [Related]
6. Breast-conserving surgery without axillary lymph node surgery or radiotherapy is safe for HER2-positive and triple negative breast cancer patients over 70 years of age.
Zhong Y; Xu Y; Zhou Y; Mao F; Lin Y; Guan J; Shen S; Pan B; Wang C; Peng L; Huang X; Li Y; Wang X; Sun Q
Breast Cancer Res Treat; 2020 Jul; 182(1):117-126. PubMed ID: 32430680
[TBL] [Abstract][Full Text] [Related]
7. Loco-regional recurrence trend and prognosis in young women with breast cancer according to molecular subtypes: analysis of 1099 cases.
Li Y; Lu S; Zhang Y; Wang S; Liu H
World J Surg Oncol; 2021 Apr; 19(1):113. PubMed ID: 33849563
[TBL] [Abstract][Full Text] [Related]
8. Hormone receptors and HER-2 status as surrogates for breast cancer molecular subtypes prognosticate for disease control in node negative Asian patients treated with breast conservation therapy.
Wong FY; Chin FK; Lee KA; Soong YL; Chua ET
Ann Acad Med Singap; 2011 Feb; 40(2):90-6. PubMed ID: 21468463
[TBL] [Abstract][Full Text] [Related]
9. Impact of molecular subtype on 1325 early-stage breast cancer patients homogeneously treated with hypofractionated radiotherapy without boost: Should the indications for radiotherapy be more personalized?
Fodor A; Brombin C; Mangili P; Borroni F; Pasetti M; Tummineri R; Zerbetto F; Longobardi B; Perna L; Dell'Oca I; Deantoni CL; Deli AM; Chiara A; Broggi S; Castriconi R; Esposito PG; Slim N; Passoni P; Baroni S; Villa SL; Rancoita PMV; Fiorino C; Del Vecchio A; Bianchini G; Gentilini OD; Di Serio MS; Di Muzio NG
Breast; 2021 Feb; 55():45-54. PubMed ID: 33326894
[TBL] [Abstract][Full Text] [Related]
10. Outcome in breast molecular subtypes according to nodal status and surgical procedures.
Mazouni C; Rimareix F; Mathieu MC; Uzan C; Bourgier C; André F; Delaloge S; Garbay JR
Am J Surg; 2013 Jun; 205(6):662-7. PubMed ID: 23312273
[TBL] [Abstract][Full Text] [Related]
11. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
[No Abstract] [Full Text] [Related]
12. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
Nguyen PL; Taghian AG; Katz MS; Niemierko A; Abi Raad RF; Boon WL; Bellon JR; Wong JS; Smith BL; Harris JR
J Clin Oncol; 2008 May; 26(14):2373-8. PubMed ID: 18413639
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.
Wang J; Wang S; Tang Y; Jing H; Sun G; Jin J; Liu Y; Song Y; Wang W; Fang H; Ren H; Yu Z; Li Y
Clin Breast Cancer; 2018 Oct; 18(5):e975-e984. PubMed ID: 30054238
[TBL] [Abstract][Full Text] [Related]
14. Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype.
Kim HJ; Han W; Yi OV; Shin HC; Ahn SK; Koh BS; Moon HG; You JH; Son BH; Ahn SH; Noh DY
Breast Cancer Res Treat; 2011 Nov; 130(2):499-505. PubMed ID: 21853352
[TBL] [Abstract][Full Text] [Related]
15. Survival After Breast-Conserving Surgery Compared with that After Mastectomy in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.
Gwark S; Kim HJ; Kim J; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Ahn SH; Lee SB
Ann Surg Oncol; 2023 May; 30(5):2845-2853. PubMed ID: 36577865
[TBL] [Abstract][Full Text] [Related]
16. Outcomes According to Breast Cancer Subtype in Patients Treated With Accelerated Partial Breast Irradiation.
Wilkinson JB; Shah C; Amin M; Nadeau L; Shaitelman SF; Chen PY; Grills IS; Martinez AA; Mitchell CK; Wallace MF; Vicini FA
Clin Breast Cancer; 2017 Feb; 17(1):55-60. PubMed ID: 27666436
[TBL] [Abstract][Full Text] [Related]
17. Role of Elective Nodal Irradiation in Patients With ypN0 After Neoadjuvant Chemotherapy Followed by Breast-Conserving Surgery (KROG 16-16).
Cho WK; Park W; Choi DH; Kim YB; Kim JH; Kim SS; Kim K; Kim JH; Ahn SJ; Lee SY; Lee J; Kim SW; Kwon J; Ahn KJ
Clin Breast Cancer; 2019 Feb; 19(1):78-86. PubMed ID: 30241965
[TBL] [Abstract][Full Text] [Related]
18. The effect of omission of adjuvant radiotherapy after neoadjuvant chemotherapy and breast conserving surgery with a pathologic complete response.
Mandish SF; Gaskins JT; Yusuf MB; Amer YM; Eldredge-Hindy H
Acta Oncol; 2020 Oct; 59(10):1210-1217. PubMed ID: 32716227
[TBL] [Abstract][Full Text] [Related]
19. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
Zhang HM; Zhang BN; Xuan LX; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
[TBL] [Abstract][Full Text] [Related]
20. A propensity score-matched analysis of breast-conserving surgery plus whole-breast irradiation versus mastectomy in breast cancer.
Magnoni F; Corso G; Maisonneuve P; Massari G; Alberti L; Castelnovo G; Leonardi MC; Sacchini V; Galimberti V; Veronesi P
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1085-1093. PubMed ID: 35254519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]